Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-773
Closed -$81.3K 249
2025
Q4
$81.3K Buy
+773
New +$72.6K 0.02% 154
2025
Q1
Sell
-1,330
Closed -$132K 226
2024
Q4
$132K Buy
+1,330
New +$137K 0.04% 118
2023
Q3
Sell
-1,971
Closed -$227K 100
2023
Q2
$227K Buy
1,971
+47
+2% +$5.34K 0.1% 96
2023
Q1
$205K Buy
1,924
+20
+1% +$2.16K 0.09% 101
2022
Q4
$211K Buy
+1,904
New +$195K 0.1% 97
2021
Q3
Sell
-725
Closed -$56K 183
2021
Q2
$56K Buy
+725
New +$53.9K 0.02% 149
2020
Q3
Sell
-760
Closed -$56K 162
2020
Q2
$56K Buy
+760
New +$57.2K 0.04% 113

Other funds holding MRK

Modus Advisors's MRK Position: Q1 2026 in Review

Modus Advisors sold out of Merck (MRK) in Q1 2026, closing a stake of 773 shares — an estimated $81.3K sold.

Modus Advisors first reported a position in MRK in Q2 2020 and held it in 7 quarters. The position peaked at $227K in Q2 2023. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Modus Advisors reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • Modus Advisors sold 773 Merck shares in Q1 2026, an estimated $81.3K.
  • Modus Advisors first reported a position in Merck in Q2 2020 and held it in 7 quarters.
  • Modus Advisors's Merck position peaked at $227K in Q2 2023.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Modus Advisors's 13F filing for Q1 2026, filed 4 May 2026.